F. Lejeune

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Mark J. Millan, Alain P. Gobert, F. Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 512 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α₂‐adrenergic and serotonin_2C receptors: a comparison with citalopram

Mark J. Millan, Alain P. Gobert, Jean‐Michel Rivet et al. · European Journal of Neuroscience · 2000 · 168 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine

M J Millan, Alain P. Gobert, F. Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 144 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Interactions of (+)- and (−)-8- and 7-Hydroxy-2-(Di-n-Propylamino)tetralin at Human (h)D3, hD2 and h Serotonin1A Receptors and Their Modulation of the Activity of Serotoninergic and Dopaminergic Neurones in Rats

F. Lejeune, Adrian Newman‐Tancredi, Valérie Audinot et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 94 citations · Full text

Medicine, Neuroscience, Pharmacology +17

S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.

Mark J. Millan, F. Lejeune, Alain P. Gobert et al. · PubMed · 2000 · 85 citations

Medicine, Neuroscience, Pharmacology +16